Table 1. Baseline characteristics.
Female [n (%)] | 22 (75.9%) |
Age [mean (sd)] | 36.99 (8.86) |
EDSS | 1.19 (1.64) |
Disease duration | 6.42 (4.72) |
Disease subtype | RRMS – 28 (96.6%), RIS – 1 (3.4%) |
Steroids at baseline | 3 (10.3%) |
Disease-modifying treatment at baseline | None – 11 (34.4%) |
Milder – 7 (21.9%) | |
Stronger – 14 (43.8%) | |
Follow-up (in years) | 2.87 (1.65) |
Number of visits | 4.84 (1.82) |